Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001294046-19-000001)

Filing Details

Accession Number:: 0001294046-19-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-03-28 18:21:02
Reporting Period:: 2019-03-26

Accepted Time:: 2019-03-28 18:21:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
926617	Vermillion Inc.	VRML	In Vitro & In Vivo Diagnostic Substances (2835)	330595156

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1294046	S James Burns	C/O Vermillion, Inc. 12117 Bee Caves Rd, Bldg 3 Ste 100 Austin TX 78738		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-03-26	34,848	$0.00	397,055	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	EMPLOYEE STOCK OPTION (RIGHT TO BUY)	Acquisiton	2019-03-26	91,451	$0.00	91,451	$1.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
91,451		2029-03-26	No	4	A	Direct

Footnotes

The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019.
The employee stock option will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019.